ACUTE MYELOGENOUS LEUKEMIA (AML)
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets leukemia stem cells in MDS and AML
Disease control Recruiting nowThis early-phase trial tests a new drug called nadunolimab combined with standard treatments (azacitidine, with or without venetoclax) in 40 adults with high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The goal is to find a safe dose and see if the combin…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML)
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 11:50 UTC
-
Experimental combo aims to tame tough cancers
Disease control Recruiting nowThis early-stage study tests two drugs—alpelisib and pembrolizumab—together in people with metastatic breast cancer or melanoma that has spread. The main goal is to find a safe dose and watch for side effects. About 50 adults whose cancer has worsened after standard treatments wi…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML)
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
New hope for fanconi anemia: gentler transplant may cut risks
Disease control Recruiting nowThis study tests a stem cell transplant using lower doses of chemotherapy drugs (busulfan, cyclophosphamide, fludarabine) for people with Fanconi Anemia who don't have a perfectly matched donor. The goal is to reduce serious side effects while still helping the body accept the ne…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 12, 2026 13:48 UTC
-
New cord blood transplant method could boost survival in tough blood cancers
Disease control Recruiting nowThis study is testing an improved method for cord blood transplants in adults with high-risk blood cancers like leukemia and lymphoma. The goal is to see if this optimized approach helps patients live longer and have fewer side effects. About 54 participants will receive the tran…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:23 UTC